Chronic Gout Drugs Could Receive Accelerated Approval, Advisory Cmte. Says

Chronic gout drugs could receive accelerated approval based on surrogate endpoints, FDA's Arthritis Advisory Committee concluded June 2

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet